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ABSTRACT 
The role of porcine circovirus type 2 (PCV2) in a newly emerged disease, 
postweaning multisystemic wasting syndrome (PMWS) was studied using two 
approaches: experimental inoculation and field-based case-control study. In the 
animal trial, 5-week-old gnotobiotic pigs free of PCV2 were inoculated intranasally 
and intramuscularly with PCV2 ISUVDL 98-15237 at a rate of 104TCIDso/ml and 
monitored for a 35-day period. Inoculated pigs were viremic at day 7 post 
inoculation (Pl) and developed virus-specific antibody response which was 
measurable by indirect fluorescent antibody and serum-virus neutralization tests. 
Viral DNA and antigens were detected in tissues with subtle histopathological 
changes (i.e., depletion of lymphocytes) at the end of the study (35 days Pl) . 
However, no clinical signs described in pigs affected by PMWS were observed in 
any of the inoculated animals during the study period. These inconclusive 
observations prompted a case-control study to assess the strength of association of 
PCV-2 and some other major swine viruses with PMWS. Cases were pigs affected 
by PMWS based on clinical and diagnostic criteria, whereas controls were clinically 
unaffected pigs. The proportion of case and control pigs positive for each virus was 
assessed and statistically compared for the association strength with PMWS. In 
addition, PCV2 isolates from 6 cases and 4 controls were selected and genetically 
compared. Type 2 PCV showed a higher association with PMWS (OR=9.3, 1.9 
<95% Cl<45.3) than other viruses. Risk for PWMS was much higher if an animal 
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was co-infected with porcine reproductive and respiratory syndrome virus 
(OR=31.2, 4.1 <95% Cl<238). However, PCV2 was also found in controls (35/56) 
and was not detected in 2 of the 31 PMWS pigs. Furthermore, no significant 
genetic difference was observed among PCV2 isolates from PMWS and clinically 
normal pigs. Collectively, na"fve swine were shown to be susceptible to PCV2. 
However, the causal role of PCV2 in PMWS could not be conclusively 
demonstrated. Development of PMWS may require additional factor(s). Since the 
virus appeared to be widespread in the U.S. swine population regardless of their 
clinical status related to PMWS, further work remains to determine the pathogenesis 
of PCV2 in conjunction with PMWS. 
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INTRODUCTION 
Thesis Organization 
This thesis begins with an abstract and is followed by review of the literature 
and a statement of the problem. Two papers present the experimental work that has 
been done. The graduate student is the principal investigator and senior author for 
both papers. This thesis concludes with a general discussion, a list of references 
cited in the literature review, general discussion, and acknowledgments. 
Literature Review 
Porcine circovirus 
History and taxonomy 
Porcine circovirus (PCV) is a small, nonenveloped DNA virus approximately 
17 nm in diameter. The virus first was recognized as a noncytopathic viral 
contaminant of a continuous pig kidney cell line PK-15 (ATCC-CCL31) (102;106). 
Based on morphology and genomic organization the virus has been classified into 
the Family Circoviridae (46) . Other members of this family include chicken anemia 
virus (CAV) and Psittacine beak and feather disease virus (PBFDV), pigeon 
circovirus, and human circovirus (46;58). Although all viruses were placed in this 
family based on the similarity of genomic organization, neither DNA sequence nor 
antigenic homology have been demonstrated among these viruses (9; 108). 
In 1998, a DNA viral agent morphologically similar to PCV was isolated from 
pigs with clinical history of progressive weight and respiratory distress in a "high-
health-status" herd in western Canada. However, the new virus is antigenically and 
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genetically distinct from PCV initially identified in the PK-15 cell line (1 ;59;60) . To 
reflect such a difference, circoviruses isolated from pigs clinically affected with 
"wasting syndrome" were designated as PCV type 2 (PCV2) and PK-15 cell line 
contaminant PCV type 1 (PCV1) (1 ;59) . Although PCV2 was recently recognized , a 
few retrospective studies presented the evidence that PCV2 was present in the 
domestic swine population as early as 1973 ( 111 ). 
Physicochemical properties 
Circoviral virions are icosahedral symmetry in shape. The virus contains 
negative-sense, single-stranded circular DNA (102). The buoyant density of PCV is 
1.33 -1.37 g/cm3 on CsCI gradient (7 ; 106).Type 1 PCV does not hemagglutinate 
erythrocytes of various animal species such as pig , sheep, cattle, chicken, turkey, 
and guinea . The virus is highly resistant to environmental stress. A study 
demonstrated that the infectivity of PCV was maintained even after exposure to pH3 
and high temperature (56°C and 70°C) for 15 minutes (7) . The PCV is stable to 
chloroform treatment, which supports that the virus is non-enveloped. 
Genomic organization and gene expression 
Sequence analysis demonstrated that the genome of PCV1 and PCV2 are 
1759 nucleotides (nt)(51) and 1768 nt long, respectively (30;58-60) . Types 1 and 2 
PCV share less than 80% nucleotide sequence homology (59;60) and 
approximately 75% amino acid homology (60) . Computer-aided analyses of PCV1 
and PCV2 DNA have identified 11 potential open reading frames (ORFs) (30). The 
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ORF1 is more conserved between PCV1 and PCV2 than other ORFs, and PCV2 
shares 83% and 86% homology with PCV1 at nucleotide and amino acid levels, 
respectively (60) . In contrast, 67% nucleotide and 65% amino acid homology was 
observed in ORF2 between PCV1 and PCV2 (60) . It was suggested that ORF2 or 
its product could be used for differentiating the two types of PCV (48) . Even less 
homology in ORFs 5, 6, 9, 10, and 11 was reported between PCV1 and PCV2 (30). 
Estimated molecular size of deduced polypeptide products encoded by 
individual potential ORF ranges from 36 to 2 kilodaltons (kO)(30) . Open reading 
frame 1 was expected to encode for the putative Rep protein , which is required for 
genome replication (50). Predicted molecular mass of ORF1 product is 35.7 kD for 
PCV1 and 35,8 kD for PCV2. Open reading frame 2 was postulated to encode for 
capsid protein , which is a major structure protein (50). Based on linear sequence 
analysis, molecular mass of ORF2 product was predicted to be 27.8 kD for PCV1 
and 27.8 kD for PCV2 (30). The predicted size of proteins encoded by individual 
ORF 3 to 11 of PCV1 was reported to be approximately 23, 13, 10, 6. 7, 6, 4, 3.4, 
3.7, and 3 kD, respectively. The molecular mass of PCV2 ORF 3 to 11 products 
was predicted to be approximately 12, 7, 6, 3, 2, 2, 5, 4, and 2 kD, respectively (30). 
Although computer-aided sequence analyses identified the presence of 11 potential 
ORFs, only one protein with molecular mass of 36kD was immunologically and 
chemically identified in the PCV1 virion (102) , suggesting that this polypeptide is the 
only structural protein. Recently, another protein with molecular mass of 31-33 kD 
has been identified in PCV1 (99) . The actual composition of PCV2 structural 
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protein(s) has not been characterized; yet a recent study suggested that ORF2 of 
PCV2 encodes for vairal capsid protein (62). 
It has been speculated that structural protein arises by splicing and 
transcription taking place in the nucleus on both DNA strands to generate three 
distinct PCV PK-15 specific RNA transcripts (59). ORF 2 and ORF 4 are more 
conserved and are possible candidates to code structural protein (59). 
There is some evidence indicating that PCV shares a degree of homology to 
plant nanoviruses (27;58) and homology with newly identified human TT virus (61 ), 
but structural protein has not been well characterized. 
Viral replication 
Based on tissue immunostaining and virus isolation, PCV has been found to 
infect many different types of cells in a variety of tissues. The virus or viral antigens 
were isolated/detected in liver, spleen, Peyer's patches of intestine, lung, tonsil, 
kidney, and other tissues except the central nervous system (5;81 ). In these tissues, 
main target cells are lymphocytes, macrophages, hepatocytes, renal tubular and 
ileal epithelial cells (81 ). Intensive basophilic or magenta inclusion bodies of 5-25 
µm in size can be seen within cells on H&E stained slides of tissues from pigs with 
circovirus infection (33;41 ). However, it is not known how porcine circoviruses 
establish infection and replicate in pigs. 
In vitro PCV can replicate in a continuous pig kidney cell line PK-15, a 
monkey kidney cell line Vero, semi-continuous pig lung cells, semi-continuous 
swine testicle cells, primary bovine kidney, semi-continuous bovine lung cells, semi-
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continuous bovine testicle cells, primary lamb kidney, semi-continuous lamb testicle 
cells, and other primary and permanent cell cultures (7). In in-vitro cell culture the 
virus does not cause visible lytic cytopathic changes in cells (7 ; 102). Therefore, the 
presence of the virus can only be demonstrated by indirect methods such as 
immunofluorescence assay (IFA) (6;22;54;91 ; 101 ), and in situ hybridization (ISH) 
(6; 13;23;54), and polymerase chain reaction (PCR) based assays (43;60). Using 
these techniques, PCV can be found in only a small number of cells in different 
tissues. Cytoplasmic inclusion bodies which consists of electron-dense 
paracrystalline arrays of small non-enveloped viral particles very heterogeneous are 
also found in inoculated cells (41 ;92). In vitro circovirus replication depends on the 
availability of cellular enzymes which are expressed during the S phase of cell 
growth (105) . Yield of progeny virus and the number of infected cells in in-vitro 
culture were found to be increased by pretreatment of cells with 300 mM D-
glucosamine-HCI, but care must be taken since the reagent has a toxic effect on the 
cell culture (6; 101 ). D-glucosamine-HCI synchronizes the cell cycle and initiates 
virus replication by enabling the PCV genome to enter the cell nucleus. If the cell is 
not treated, the virus will enter the cell nucleus of the daughter cell at the end of 
mitosis, resulting in a very few cells infected (105) . Early protein(s) and non-
structural protein(s) of PCV are involved in induction of viral DNA to replicate and 
regulate this process (104). Accumulation of structural protein is an independent 
process from DNA synthesis, which takes place in cytoplasm of infected cells and 
causes cell destruction, however visible cytopathic effect could be demonstrated on 
limiting cell layers and colonies in soft agar (104) . 
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It has been proposed that circovirus replicates via a double stranded 
replicated form (RF) by rolling cycle replication (51 ;58). The predicted product of 
ORF 4 encodes a Rep protein of 312 amino acids which shows similarities to 
replication proteins of other plant circoviruses and geminiviruses (50). 
Epidemiology 
Prevalence and geographic distribution. The presence of PCV has been 
reported at least serologically in the USA, Canada, Northern Ireland, France, Spain, 
Great Britain, Korea, and Germany (6;13;19;21;41;45;88;100). The limited numbers 
of serological surveys have demonstrated that PCV infection is ubiquitous among 
the swine population (7; 19; 100; 103; 111 ). In one study, prevalence of PCV infection 
was estimated to be 95 percent in the German swine population (105). However, 
early serological surveys were conducted using PCV1 as antigen. Recent studies 
revealed the cross reactivity between PCV1 and PCV2 (6;48) . Consequently, 
accurate prevalence of PCV1 or PCV2 infection needs to be re-assessed. Recently, 
using a multiplex polymerase chain reaction assay which allows typing of PCV, it 
has been demonstrated that PCV2 is the main type of PCV circulating in the swine 
population (24;43). Only 4-8% of the virus present in the field was PCV1. 
Transmission mode. Field observations suggested that PCV can cross the 
placenta and infect fetuses, i.e., congenital infection (5). PCV2 has been detected 
in hearts or fetal thoracic fluids of aborted or stillborn fetuses (Janke BH, personal 
communications) . Experimentally, vertical transmission was demonstrated by 
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inoculating a sow with PCV1 during pregnancy and attempting to isolate the virus 
from fetuses at term or the litter of pigs right after the birth (35); (Joo HS, personal 
communication). 
Types 1 and 2 PCV were found in nasal secretions and feces from 
experimentally inoculated pigs although animals did not show any clinical signs or 
pathological changes (5;42; 103). These observations indicate that horizontal 
transmission may occur. 
Pathogenicity and disease 
Although early sero-epidemiological surveys demonstrated that PCV1 was 
prevalent in swine, the virus has been detected by PCR assays in about 4-5% of 
pigs with no clinical signs or histopathological lesions of PMWS(43;49) and 5.7% of 
pigs with histopathological lesions typical for PMWS (72). Under experimental 
conditions, PCV1 was detected in various tissues of inoculated animals and shed in 
nasal secretions and through feces, suggesting that na"fve pigs are susceptible to 
PCV1 (5; 103). These observations also suggest that the virus can be transmitted 
to pen mates. Horizontal transmission was demonstrated in pigs commingled with 
inoculated pigs. However, experimental inoculation of PCV1 failed to induce any 
pathological changes and clinical disease in pigs, suggesting that PCV1 is not 
pathogenic for swine (42;103). In contrast, tremors were reproduced in young pigs 
inoculated with PCV1 isolates from newborn piglets clinically affected by congenital 
tremor, but the virus was not genetically or antigenically characterized (35). 
Furthermore, PCV1 was found in aborted fetuses collected from the field in 
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conjunction with reproductive failure and also in fetuses obtained from pregnant 
sows inoculated with the virus, suggesting that the virus can cross the placental 
barrier. However, the significance of these findings is unknown. 
Type 2 PCV has been implicated in dermatitis/nephropathy syndrome (2;81 ), 
pig tremors (35) , and wasting syndrome (22;33). However, a causal role of PCV2 in 
these diseases has not been conclusively demonstrated under experimental 
conditions. 
Other circoviruses 
Chicken anemia virus (CAV) 
The virus was first identified in Japan from chickens with clinical signs such 
as depression, severe anemia and reluctance to move with 50% mortal ity (116). 
Clinically CAV infection is characterized by slow growing chicks, depression, ruffled 
feathers, anemia and marked pallor that extends to internal organs (113) . 
Serological surveys indicated that this virus is ubiquitous in commercial chicken 
flocks (56). 
Chicken anemia virus is a icosahedron and contains 2.3kb single-stranded 
circular DNA (56; 107). The size of the virion is approximately 18-26 nm in diameter 
and the density is 1.35-1.36 g/ml (57; 107). The virus is antigenically and genetically 
distinct from PCV and psittacine beak and feather disease (BFDV) (9; 108). Three 
ORFs have been identified and encode for 3 putative proteins with molecular weight 
of 51 .7, 24.1 , and 13.3 kDa, respectively (67) and only one protein with molecular 
mass of 50 kD was detected using an electrophoresis system (107). 
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Chicken anemia virus has been reported to be associated with other 
diseases or syndromes in chicken, such as blue wing disease, hemorrhagic anemia 
syndrome, gangrenous dermatitis, and aplastic anemia (53). In severe cases when 
naive hens are infected with CAV, infected animals show anemia, subcutaneous 
hemorrhages and gangrenous dermatitis, which leads to enhanced susceptibility to 
secondary viral or bacterial infections (82;83) . The virus can be detected in all 
tissues, but thymus and bone marrow are reported to be the most severely 
damaged (98) . Usually infected birds die but some may recover after 3-4 
weeks(83). 
Experimentally the disease was demonstrated in chicks inoculated with CAV 
at one day of age but was more difficult to be reproduced in chicks at 3 weeks of 
age or older or in chickens with neutralizing antibody (114). The pathogenicity of 
CAV in chickens is reported to be enhanced when concurrently infected with 
infectious bursa disease virus (IBDV) or Marek's disease virus (MDV) (115). Dual 
infection results in much higher mortality and morbidity and more severe lesions 
than CAV infection alone (55). 
Histopathological lesions in infected chickens are characterized by 
lymphocyte depletion in the cortex and medulla of thymus and bone marrow. 
Infected chickens are also depleted of erythrocytes, thrombocytes and 
granulocytes, and precursors of these cells are replaced by adipose tissue (83). 
The bursa of Fabricius and spleen are also depleted of lymphoid cells but less 
severely than the thymus (83). There is some degree of swelling in the liver and 
Bursa of Fabricius. Muscular atrophy and hemorrhage has been observed 
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(98; 116). Severe lymphoid depletion in lymphoid tissue and the hematopoietic 
system lead to the speculation that CAV may induces immunosuppression. In one 
study, immune response of infected chickens to different vaccines was depressed 
after inoculation with CAV (71 ). 
Exposing breeder flocks to the virus before chickens go to egg production 
prevents transovarian transmission. Acquired immunity in the flock is known to 
prevent from vertical transmission and horizontal transmission for 1 day till 2 wk 
(83). In the United States, the current control strategy for CAV is to expose 
serologically negative birds at 12-15 weeks of age to known positive flocks (25). In 
Europe, vaccination with autogenous live virus vaccine has been proven to prevent 
vertical transmission of CAV by mimicking natural infection (25) . Hens that are 
hyperimmunized with an inactivated CAV vaccine perform better than unvaccinated 
hens and have better body weight gain, livability, and feed conversion rate. 
Furthermore, vaccination was reported to be efficacious in protecting chicks from 
developing the disease on a farm with ongoing disease problems (25). 
Psittacine beak and feather disease virus {PBFDV) 
The PBFDV is another member of Circoviridae family and a circular single-
stranded DNA virus with icosahedral symmetry (80). The virus infects a wide variety 
of species of wild and captive birds and causes anorexia, vomiting , weakness, 
dystrophic feathers, deformity of beak and bones. In some cases, severe 
leukopenia or anemia and pancytopenia have been observed (87). 
11 
Histopathologically hepatic, necrosis and atrophy of lymphoid follicles with 
occasional necrotic foci and typical circoviral basophilic, polymorphic inclusion 
bodies are frequently observed (87) . Depletion of lymphoid tissue and necrosis was 
reported in naturally exposed birds (73) . Necrosis and degeneration of epithelial 
cells lining the developing feathers follicles are common since the virus infects and 
replicates in these cells (37;44;78). The virus can also be detected in the thymus 
and bursa with mild infiltration of the cells and necrosis of severely infected cells in 
the beak and feather follicle. Necrosis of epithelial cells of the tongue, and mouth 
has been reported (37;78). 
Birds can harbor the virus for 10-15 years once exposed, and most develop 
cryptosporidial infections that generally occur in birds with immunodeficiency. The 
majority of infected adults develop viremia; however, birds with good established 
humoral and cell-mediate immunity clear the virus and undergo asymptomatic 
infection (79). Several factors are considered to be important as to whether birds 
will have protective immune response or develop fetal disease. Some of these 
factors include the presence or absence of maternal antibodies, route of viral 
exposure, exposure dose, and presence or absence of some conditions where birds 
become immunotolerant (77) . 
TT virus 
In 1997, a novel DNA initially designated 'N22 sequence' was detected by a 
representational difference analysis and PCR in sera from patients who developed 
elevated alanine aminotransferase (ALT) levels and clinical hepatitis some time 
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after receiving blood transfusions during surgical operations in Japan (65). The 
patients were negative for known etiological agents of Hepatitis A to G. The N22 
sequence was not detected in sera collected from these patients prior to the blood 
transfusion. A material that contains the N22 sequence was fractionated on sucrose 
gradient (1.26 g/cm3) from plasma obtained from a blood donor positive for the N22 
sequence. Because of its density, filterability and resistance to DNAse digestion, 
the fractionated material was suspected to be virus particles and named TT virus 
(TTV) after the initials (T.T.) of the patient from whom the N22 sequence was first 
detected and cloned (65). After the initial discovery of TTV, the detection of TTV 
DNA in individuals with hepatitis symptoms has been reported in many other 
countries, such as Taiwan, Brazil, Egypt, Vietnam, Italy, and USA 
(11; 12;15;26;38;52;63;64;70;7 4). 
To date, no successful isolation of TTV has been made from clinical 
specimens using in vitro cell culture techniques. Based on biophysical 
characteristics, TTV is believed to be a non-enveloped DNA virus since the 
infectivity was maintained after treatment with chemicals capable of disrupting the 
viral envelope (69). The size of the virus was estimated to be 30-50 nm in diameter 
using a filtration technique (61 ). The buoyant density of the virus is 1.31-1.34 g/ml 
in cesium chloride gradient (61 ). 
The genome of TTV is a circular single-stranded, negative-sense DNA with 
the size of 3, 818 - 3,853 bases depending upon genotype (61 ;69). Genetic 
analyses identified two putative open reading frames (ORF1 and ORF2) that are 
flanked by a noncoding region of approximately 1.2 kilobases. The noncoding 
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region is divided into 2 by a GC rich stem loop structure present in the middle of the 
region. The ORF1 consists of 2,283 - 2,310 bases depending upon genotype, 
which encodes for a polypeptide consisting of 761 - 770 amino acids (66;69;97). 
The N22 sequence is a part of ORF1 , which has been shown to be highly conserve 
among TTV isolates within the same genotype (97). Hypervariable regions of ORF1 
were also identified among isolates, particularly those collected during the chronic 
stage of infection (66) . Although the genomic structure of TTV ORF1 is similar to 
that of CAV replicase gene (ORF1 ), a recent molecular characterization suggests 
that ORF1 should encode for the nucleocapsid protein (69) . Nonetheless, it is not 
known whether ORF1 product can be immunologically recognized . 
The ORF2 consists of 450 - 609 bases depending upon genotype, and is 
postulated to encode for a nonstructural protein of 150 - 203 amino acids in length 
and play a role in virus replication (61 ;69). A recent in vitro translation study 
demonstrated the ORF2 product with molecular mass of 23 kD (97) . However, TTV 
isolates of some genotypes contain an in-frame stop codon that takes the ORF2 
apart (i .e., ORF2a and ORF2b), resulting in a protein product with a molecular mass 
of 17kD. The ORF2 has been demonstrated to be highly variable among isolates of 
TTV (97). 
Genomic structure, gene expression strategy and biophysical characteristics 
of TTV are very similar to those of members in the Family Circoviridae; yet it is 
distinctly different from circoviruses. TTV contains the a genome almost twice as 
large as circoviruses. There are several distinct genotypes reported , demonstrating 
significant genetic heterogeneity among TTV (95) . In addition, no serological cross 
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reactivity between TTV and circoviruses has been demonstrated. At present, TTV is 
tentatively classified into the Family Circonoviridae (61 ). 
TTV has been reportedly associated with post-transfusion non-A to G 
hepatitis in humans, although Kock's postulates have not yet been fulfilled. 
Hospital-based descriptive studies showed an increase and then a decrease in the 
level of TTV DNA in sera collected over time from patients with post-transfusion 
hepatitis with unknown etiology and elevated ALT level (7 4; 109). In these patients, 
development of TTV-specific serum antibody followed the disappearance of TTV 
DNA from the serum. DNA of TTV has also been detected in peripheral blood 
mononuclear cells and bone marrow from such patients (40). 
Besides accidental transmission of TTV through blood transfusion or blood 
products in humans (47;61 ;65), some species of non-human primates were shown 
to be susceptible to TTV under experimental conditions. Chimpanzees injected with 
human serum or plasma containing TTV which were collected from patients with 
non-A to G hepatitis developed viremia (61 ;68). The TTV genome was detected by 
PCR as early as 98 days postinoculation. Thereafter, the animals were viremic for 
as long as 70 days after initial detection. In addition, oro-fecal transmission of TTV 
was also demonstrated in Rhesus monkeys inoculated orally with the virus 
extracted from the stool of humans positive for TTV (47). The monkeys developed 
viremia of TTV. Eventhough virus replication was readily established in inoculated 
animals, neither abnormal blood chemistry nor histopathological evidence of 
hepatitis was observed in the inoculated animals (47;61 ). 
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Although the TTV genome is frequently found in patients with hepatitis, 
epidemiological surveys using the PCR technique on randomly selected human 
subjects suggest that the virus is ubiquitous in the human population 
(17; 18;29;36;7 4) . No difference in the frequency TTV detection or the level of TTV 
in serum was found between individuals with and without hepatitis or altered ALT 
levels. Despite the ubiquity of TTV in the human population, a correlation between 
the TTV infection and any specific disease has not yet been establ ished. 
Furthermore, no association of virus infection with pathological changes has been 
identified. Consequently, the etiological role of TTV in hepatitis is still in question 
(94;96). Clinical significance and pathogenesis of TTV infection remains to be 
determined. 
Postweaning multisystemic wasting syndrome (PMWS) 
Clinical manifestation 
Postweaning multisystemic wasting syndrome is a newly emerged problem 
in the swine industry. The syndrome was first recognized in so-called "high health 
status" swine herds in western part of Canada (14;31) and thereafter, in the United 
States, Northern Ireland, Spain, South Korea, France, Japan (6; 13;22;33;86;88). 
The syndrome was most commonly observed in growing pigs at 4-16 weeks of age. 
Cardinal clinical signs commonly observed in affected animals are progressive 
weight loss, tachypnea, unthriftness and less commonly, icterus, jaundice and 
diarrhea. Morbidity typically ranges between 5 and 15% in an infected herd (34;90) 
but mortality among affected pigs can be up to 80% (34) . 
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Pathological findings 
Typical gross lesions in affected animals are lymphadenopathy (e.g., 
enlargement of inguinal lymph node), icterus, renal petichiae, noncollapsed and 
mottled lungs, skin pallor, yellowish liver with some atrophy, and enlarged spleen. 
Intestines are filled with fluid with occasional edema of the wall of the cecum. 
Stomach ulcers and edema of the gastric wall have been observed (6; 14;22). 
Microscopically depletion of lymphocytes in secondary lymphoid tissues, 
interstitial pneumonia, and lymphohistiocytic to granulomatous inflammation in 
multiple organs, predominantly lungs and lymphoid tissues, liver, kidney, pancreas 
and intestine, are commonly observed (6; 14;22). Characteristic microscopic 
changes in lymphoid tissues include lymphocyte depletion with pyknosis and 
karyorrhexis in lymphoid follicles and extensive macrophage infiltration. Lymphoid 
hypoplasia and macrophage infiltration of cortex and medulla with syncytia 
formation were also reported (39). Histopathological changes in livers of affected 
pigs are characterized as histiocytic infiltration and severe diffuse hepatocytic 
necrosis (3). Renal lesions are mild pyelitis and interstitial nephritis characterized by 
focal lymphohistiocytic infiltrates with corticomedullary congestion and hemorrhage 
associated with perivasculitis (39). Many times basophilic cytoplasmic inclusion 
bodies are observed in various tissues of affected pigs, most commonly in lymph 
nodes, tonsil, and Peyer's patches of the ileum (81 ). At present, observation of 
characteristic histopathological lesions in conjunction with clinical signs is the basis 
for diagnosing PMWS (33). 
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Postulated etiology 
Type 2 PCV has been most frequently isolated from or detected in pigs with 
clinical signs and histopathological lesions typical of PMWS (6;22;31 ;33) . The 
presence of PCV2 has been demonstrated in tissues with histopathological lesions 
using immunohistochemistry. However, results of animal inoculation studies are 
inconsistent. The majority of animal trials failed to reproduce any pathological 
changes or clinical signs in inoculated pigs, although the virus or vi ral antigens were 
detected in trachea, lung, liver, kidney, pancreas, lymph nodes, spleen, thymus, 
ileum, colon, cecum, salivary gland, heart, brain, testis (39;81 ). On the other hand, 
in a few studies, inoculated pigs showed mild microscopic changes, such as subtle 
lymphoid depletion and hepatic necrosis, and some nonspecific clinical signs. 
(3;39;42). Therefore, Koch's postulates have not yet been fulfilled. 
Since pigs inoculated with PCV2 alone did not develop any cl inical signs or 
gross lesions, it has been speculated that other factors may be required in the 
reproduction of the PMWS-specific clinical signs and lesions (3). Some 
histopathological lesions characteristic of PMWS such as lymphoid depletion have 
been reproduced in gnotobiotic or colostrum-deprived pigs concurrently infected 
with PCV2 and porcine parvovirus (3;23;39;42). Diagnostic observations suggested 
that it is common that animals affected by PMWS are concurrently infected with 
PRRSV and PCV2 (2;90). Such animals showed more severe clinical 
manifestations than animals infected with PRRSV alone. In one recent publication, 
lesions and clinical signs of PMWS were reproduced in colostrum-fed pigs by PCV2 
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inoculation followed by injection of commercial Mycoplasma hyopneumonia and 
Actinobacillus pleuropneumoniae vaccines. Approximately 21 % of treated pigs 
developed clinical signs typical of PMWS and histopathological changes. The 
percentage of animals that were diagnosed with PMWS in th is particular study was 
similar to that of morbid animals in a farm affected by PMWS. In addition, 
management and environmental factors are also considered to contribute to the 
development of PMWS. 
Control and prevention 
From the time of the first report of PMWS in the swine population, there has 
been no good method for controll ing this syndrome and preventing the virus 
spreading among animals. No vaccine is commercially available at present. 
Porcine circovirus is known to be very hard to inactivate and strongly resistant to 
environmental stress (34; 103). No therapeutic treatments that can be used in the 
field have been reported . Consequently, it appears that good management 
practices help reduce the risk for PMWS. For example, all-in/all-out production 
systems, feeding pigs with multivitamins, minimizing stress, and handling pigs with 
extra care may have some benefit. However, high rates of mortality were still 
observed in some cases even after implementing good management practice (8). 
Segregated early weaning (SEW) has also been practiced with some preventive 
effect on this syndrome since most of the pigs are known to be weaned negative 
and then exposed to PCV during the growing period (100). In SEW, pigs are 
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weaned and removed to a remote area while maternal antibodies are still at 
protective level. 
Administration of corticosteroid appears to be beneficial for reducing the 
severity of disease and death loss during an acute outbreak of PMWS. Treatment 
with 0.5 mg/kg corticosteroid intramuscularly improved pig condition after 48 hrs, 
and decreased mortality dramatically (8) . This observation suggests that the 
syndrome may be an the immune-mediated disease since corticosteroid has effects 
on the immune system. 
Statement of the problem 
Porcine circovirus or PCV1 was first identified in 197 4 ( 106) as a 
noncytopathic viral contaminant of PK-15 cell line and has been known to be 
nonpathogenic to swine except that the virus has been impl icated in congenital 
tremor in newborn piglets. In the late the 1990's, PCV2, which is genetically and 
antigenically distinct from PCV1, was recognized in pigs affected by postweaning 
multisystemic wasting syndrome (PMWS) which is characterized cl inically by 
progressive weight loss and pathologically severe lymphoid depletion. While PCV2 
has been reportedly associated with PMWS during diagnostic investigation, Koch 's 
postulates have not been fulfilled yet through experimental animal trials with PCV2. 
In addition, PCV2 appears to be prevalent in the swine population; yet it is in 
question why such a small proportion of animals in a given herd are clinically 
affected by PMWS if PCV2 is responsible for the syndrome. Consequently, the role 
20 
of PCV2 in PMWS needs to be assessed and the pathogenesis of PCV2 infection 
studied. 
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CHARACTERIZATION OF IMMUNE RESPONSE OF YOUNG PIGS TO PORCINE 
CIRCOVIRUS TYPE 2 INFECTION 
A paper published in the Journal of Viral Immunology 
Roman M. Pogranichnyy1, Kyoung-Jin Yoon 1, Perry A Harms 1, 
Sabrina L. Swenson2,Jeffrey J. Zimmerman 1, Steven D. Sarden 1 
ABSTRACT 
A longitudinal study was conducted to characterize the immune response of 
young swine to infection with porcine circovirus type 2 (PCV-2). Five 8-week-old 
caesarian-derived, colostrum-deprived pigs were inoculated intranasally and 
intramusularly with a field isolate of PCV-2 at a concentration of 104 TCID50/ml. 
Along with monitoring for clinical signs and viremia, serum samples were collected 
from all pigs at day 0 and thereafter every 7 days post inoculation (Pl) until the 
termination of the study on day 35 Pl. No clinical signs were observed in any of the 
animals during the study period. In all pigs, PCV-2 was detected by PCR in serum 
samples collected on days 7, 14, and 21 Pl. Viral DNA and antigens were detected 
by in situ hybridization and immunohistochemistry in tonsil , spleen, medial iliac 
lymph nodes, and ileum collected from each pig at the end of the study. 
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Collectively, na"fve young swine were shown to be susceptible to PCV-2. Virus-
specific antibody was detected by an indirect fluorescent antibody (IFA) assay on 
day 14 Pl , but virus neutralizing antibody was not detected until day 28 Pl. As 
neutralizing antibodies developed, cross-reactivity with PCV type 1 (PCV-1) also 
developed on the IFA test. Western immunoblot analysis revealed 3 PCV-2 
proteins with molecular masses of 28kD, 28.5kD, and 35kD. The 35kD protein was 
also demonstrated in PCV-1, suggesting that this protein induced the cross-
reactivity between PCV types 1 and 2. Antibody to the 28kD protein was detected 
on day 14 Pl and later, indicating that this protein was the most immunogenic. 
Because of its immunogenicity and specificity to PCV-2, the 28kD protein might 
provide the antigenic basis for the development of diagnostic tests for detection of 
PCV-2 antibody. 
INTRODUCTION 
Porcine circovirus (PCV) is a small, negative-sense, single-stranded DNA virus 
(19, 27) and was first detected as a noncytopathic viral contaminant of a continuous 
pig kidney (PK-15) cell line (5, 29). Morphologically, the virus is a nonenveloped 
virion with icosahedral symmetry (20, 27). The size of the virus is 15-17 nm in 
diameter. The genome is 1. 76 kilobases in size. Along with chicken anemia virus, 
psittacine beak and feather disease virus, and pigeon circovirus, PCV is classified 
as a member of Family Circoviridae (18). No sequence homology and antigenic 
relatedness have been demonstrated among these circoviruses (30) . 
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Several independent serologic surveys of swine in Canada, Germany, United 
States, and other countries revealed that the virus is highly prevalent in domestic 
swine (5, 6, 12, 26, 28). Antibodies cross-reactive to PCV were also detected in 
humans, mice, and cattle (25). Despite the common occurrence of PCV antibodies 
in swine, the virus has not been associated with a specific disease in pigs (1 , 28). 
No cl inical disease or pathological changes have been demonstrated in pigs 
experimentally infected with PCV (1 ). 
Recently, a disease termed "postweaning multisystemic wasting syndrome" 
(PMWS) was reported in swine. In 1996, the syndrome was described in "high 
health" status swine herds in Canada and, shortly thereafter, in the United States 
and Europe (2, 4, 7, 13, 17, 22, 23). The cardinal clinical manifestation of PMWS is 
progressive weight loss in pigs at 4- to 16-weeks of age (2, 11, 17, 23). Other 
commonly reported clinical signs include tachypnea, dyspnea, icterus, and diarrhea. 
Characteristic histopathological changes observed in affected pigs include a varying 
degree of depletion/atrophy of lymphoid tissues and granulomatous inflammation in 
any tissue, particularly lymphoid tissues, lung or intestine (8, 10, 14, 23). 
A circovirus that is genetically and antigenically distinct from the PCV originally 
found in a PK-15 cell line has been repeatedly isolated from and/or detected in pigs 
diagnosed with PMWS (2, 3, 9, 14, 16, 21 ). The overall DNA sequence homology 
between these two viruses was reported to be 68-76% (9, 20, 21 ). To reflect such a 
difference, it has been proposed to designate the field virus PCV type 2 (PCV-2) 
and the PK-15 cell contaminant PCV type 1 (PCV-1) (20) . A computer-aided 
analysis of PCV-2 genomic sequences has suggested that the virus may contain as 
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many as 11 open reading frames (ORFs) (9). The predicted size of proteins 
encoded by individual ORFs is reported to be approximately 36, 28, 12, 7, 6, 3, 2, 2, 
5, 4, and 2 kilodaltons (kD), respectively. ORFs 1 and 2 are considered to encode 
for two major structural proteins of PCV-2. Nucleotide sequence identity of ORFs 1 
and 2 between PCV-1 and PCV-2 was determined to be 83-85% and 66-67%, 
respectively (9, 21 ). 
However, actual protein constituents of PCV-2 and their immunobiological roles 
have not been characterized. Furthermore, at the present time, there are no 
published reports documenting clinical disease and pathological changes in pigs 
experimentally infected solely with PCV-2, although one study revealed that pigs 
developed antibody to the virus after infection (8) . The following animal trial was 
conducted to characterize immune responses of pigs at an age apparently 
susceptible to infection with PCV-2. In the course of the study, clinical and 
pathological responses of pigs to PCV-2 infection were also assessed. 
MATERIALS AND METHODS 
Experimental design. A longitudinal study was conducted. Five, 5-week-old 
cesarean-derived, colostrum-deprived pigs were obtained and housed in the 
biosafety level 3 animal facility at the National Animal Disease Center, USDA/ARS, 
Ames, Iowa, USA. Prior to inoculation, pigs were tested twice for the presence of 
serum antibodies against PCV types 1 and 2 by an indirect fluorescent antibody 
(IFA) test at 2-week intervals and confirmed negative for both types of PCV. The 
pigs were also tested for serum antibodies against major swine pathogens, i.e., 
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porcine reproductive and respiratory syndrome virus (PRRSV), Aujeszky's disease 
virus (ADV), transmissible gastroenteritis virus (TGEV), swine influenza virus (SIV) , 
porcine parvovirus (PPV), hemagglutinating encephalomyelitis virus (HEV), porcine 
enteroviruses (PEV), and porcine cytomegalovirus (PCMV). At approximately 8 
weeks of age each animal was inoculated with an isolate of PCV-2 recovered from 
a pig diagnosed with PMWS. Each animal was exposed via intranasal (1 ml/nostril) 
and intramuscular (2 ml/pig) routes with suspension containing virus at 104 
TCID5o/ml. All pigs were monitored for 5 weeks post inoculation (P l) and clinical 
signs, such as nasal discharge, skin color, skin lesions, locomotion, appetite, and 
attitude, were recorded daily. A single investigator made all clinical observations. 
Pigs were bled on the day of inoculation and every 7 days thereafter during the 
study period. Serum was separated and stored at -80°C unti l tested. Viremia was 
monitored by a polymerase chain reaction (PCR) assay. Antibody response to 
PCV-2 and PCV-1 was assessed using an indirect fluorescent antibody (IFA) test, a 
virus neutralization (VN) assay, and western immunoblotting. At the end of the 
study, all animals were euthanized and tissues collected in 10% neutral buffered 
formalin for histopathological examination (lung, tonsil , spleen, liver, kidney, ileum, 
medial iliac lymph nodes). Formalin-fixed tissues were also assayed for the 
presence of PCV-2 by in situ hybridization (ISH) and immunohistochemistry (IHC) 
techniques. Serum samples collected at the end of the study were checked for 
antibodies against the swine pathogens described above and classical swine fever 
virus (CSFV) at the National Veterinary Service Laboratories (NVSL), 
USDA/APHISNS, Ames, Iowa, USA In addition, the samples were tested by IFA 
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and VN tests against 4 other field isolates of PCV-2 obtained from cases that were 
submitted to the Iowa State Veterinary Diagnostic Laboratory (ISUVDL) and 
diagnosed as PMWS. 
Virus and cell. A field isolate of PCV-2 designated ISUVDL 98-15237 was used 
to challenge pigs in the study. The virus was isolated using PK-15 cells at the 
ISUVDL from tissues collected from a pig originating from a herd undergoing a 
clinical outbreak diagnosed as PMWS. The virus was purified by ultra filtration 
using a series of filters (Fisher Scientific, Pittsburgh, PA, USA), the final filter pore 
size being 20 nm in diameter. The absence of PCV-1 in the virus preparation was 
confirmed by both ISH and PCR prior to use. The virus used in this study 
represented six in-vitro passages in cell culture. The complete virus sequence can 
be found in GenBank (accession number AF147751 ). 
Polymerase chain reaction. A multiplex PCR assay was developed and used 
to detect and differentiate between the nucleic acid of PCV types 1 and 2 in serum. 
DNA was extracted from 0.2 ml of each serum sample using QIAamp Tissue Kit 
(Qiagen, Santa Clarita, CA, USA), as recommended by the manufacturer. Two µI of 
each extract were used for amplification. PK-15 cells infected with PCV-2 and day 
0 serum samples were used as positive and negative controls, respectively. 
Primers were designed based on nucleotide sequences of type 1 and 2 porcine 
circovruses available from GenBank. Primer 1 C478 (5'-
CCGCGGGCTGGCTGAACTT-3') was designed to amplify both PCV-1 and PCV-2. 
Primers 1C1108 (5'-CTCGGCTATGCGCTCCAAAATG-3') and 2C16R(5'-
ACCCCCGCCACCGCTACC-3') were designed to detect PCV-1 and PCV-2, 
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respectively. The PCR was performed in 35 cycles with the following parameters: 
denaturation at 94°C for 20 seconds, annealing at 62°C for 20 seconds, and 
elongation at 72°C for 20 seconds. Amplification products were separated on a 
1.5% agarose gel and stained with ethylene bromide. Samples containing PCV-1 
and PCV-2 resulted in 1154-bp and 652-bp products, respectively. 
Indirect fluorescent antibody test. The IFA test was performed to detect 
antibody specific for PCV-1 and PCV-2, as previously described (2, 5) . A 
suspension of PK-15 cells was prepared in MEM (Sigma Chemical Co., St. Louis, 
MO, USA) supplemented with 10% fetal bovine serum (FBS) and an antibiotics-
antimycotic mixture (MEM growth medium) at a concentration of 4 x 105 cells/ml. 
Type 2 PCV antigens were prepared by adding the virus (104·5 TCID50/ml) to the 
suspension of PK-15 cells at a ratio of 1 :50, seeding inoculated cells in 96-well 
plates, and incubating the cells at 37°C in a 5% CO2 atmosphere. After 20 to 24 
hours of incubation, the cells were treated (25 µI/well) with 300 mM D-glucosamine 
(Sigma Chemical Co. , St. Louis, MO, USA) prepared in MEM for 20 minutes. Cell 
monolayers were washed once with MEM supplemented only with the antibiotics-
antimycotic mixture and replenished with 200 µI of fresh MEM supplemented with 
15% FBS and the antibiotics-antimycotic mixture. The cells were incubated for 
another 16 hours, then fixed in cold 80% aqueous acetone. Type 1 PCV antigens 
were prepared in the same manner. Uninfected PK-15 cells served as negative 
control antigens. 
For the IFA test, serum samples were serially diluted 2-fold in 0.01 M 
phosphate-buffered saline (PBS) at pH 7.4. Each diluted sample was added to 
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PCV-2 infected or PCV-1 infected cell monolayers, as well as negative control cells. 
Plates containing the antigen-serum mixture were incubated for one hour at 37°C. 
The cells were rinsed with PBS three times. The antigen-antibody reaction was 
visualized by staining the cells with optimally diluted goat anti-porcine lgG (H+L) 
conjugated with fluorescein isothiocyanate (Kirkegard and Perry Laboratories, Inc. , 
Giathersburg, MD, USA). Antibody titers for individual samples were determined as 
the reciprocal of the highest dilutions in which specific fluorescence staining was 
observed, as illustrated in Figure 1. 
Virus neutralization test. The VN test was performed in 96-well microtitration 
plates using PK-15 cells as the indicator. Serum samples were heat-inactivated at 
56°C for 30 minutes prior to performing the test. In a 12 x 8 format, 100 µI of MEM 
growth medium were added to wells , starting at the second well of each raw in a 96-
well plate. Each serum sample was then added to the first well that did not contain 
the medium and serially diluted 2-fold up to 1 :512. The first well was used as serum 
control for each sample to check the cytotoxicity. The last two wells were used as 
mock-infected and virus-infected cell controls, respectively. One hundred µI of 
PCV-2 at a rate of 200 TCIDso/0.1 ml were added to each well containing an equal 
volume of each sample dilution except the first and second last wells. Plates 
containing mixtures of virus-serum or virus-medium, medium only, and serum only 
were incubated at 37°C for 60 minutes. After that, 100 µI of the cell suspension 
prepared in MEM growth medium at a concentration of 4 x 105 cells/ml were added 
to each well. 
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Figure 1. lmmunofluorescence microscopy on PK-15 cell monolayers not infected 
(A) and infected (B) with PCV-2 using PCV-2 specific hyperimmune serum. 
Infected cells show intensive nuclear staining. 
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Plates were placed in a 37°C humidified CO2 incubator. After a 48-hour 
incubation, the resulting cell monolayers were treated with 300 mM D-glucosamine, 
as described above. After an additional 16 hours of incubation, the cells were fixed 
in cold 80% acetone. Since no visible cytopathic effect was expected, growth or 
suppression of virus replication in inoculated cells was confirmed by 
immunofluorescence microscopy and the number of fluorescent foci was counted. 
Virus neutralizing antibody titers were expressed as the highest dilution in which no 
or higher than 80% reduction of virus replication was detected as compared to the 
virus control. 
Preparation of the antigen for western immunoblot analysis. A PK-15 cell 
suspension was prepared in MEM growth medium at a concentration of 4 x 105 
cells/ml and inoculated with PCV-2 of 105 TCIDso/ml at a ratio of 1 ml virus per 50 
ml cell suspension. Inoculated cells were seeded into a 165-cm2 tissue culture flask 
and incubated for 24 hours. The resulting cell monolayers were treated with 300 
mM D-glucosamine for 30 minutes and incubated for another 48 hours. Virus-
infected cells were then freeze-thawed twice, harvested using a cell scraper, and 
pelleted by centrifugation at 3,000 x g for 10 minutes. Supernatant was saved as 
virus antigens. The cell pellet was then resuspended and disrupted in a lysis buffer 
(0.05 M Tris, 0.15 M NaCl , 0.002 M EDTA, 0.1 % SOS, 1%TritonX-100, 0.1 % 
sodium azide, pH 8.0) at a rate of 1 ml buffer per 0.1 ml of the cell pellet. The 
suspension was stirred for 15 minutes at 4°C and centrifuged at 3,000 x g for 10 
minutes. The supernatant was mixed with the cell culture supernatant that was 
saved earlier and ultracentrifuged at 190,000 x g for 3 hrs. The pellet was 
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resuspended and disrupted in the lysis buffer at 4°C for another 6 hours. PCV-1 
and negative cell control antigens were prepared in the same manner. The protein 
concentration in each sample preparation was determined using the Bio-Rad 
protein assay kit (Bio-Rad Laboratories, Richmond , CA, USA) following the 
manufacturer's recommended procedures and adjusted to 2 mg/ml. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SOS-PAGE). 
A modified Laemmli procedure was used for protein separation (15) on a 
discontinuous slab gel (70 x 80 x 0.75 mm) consisting of 5% stacking gel and 12.5% 
resolving gel cross linked with bis-acrylamide (Bio-Rad Laboratories, Richmond, 
CA, USA). The viral (PCV-1 and PCV-2) and cell antigen preparations described 
above were solubilized in a sample buffer (pH 6.9) containing 0.0625 M Tris, 2% 
SOS, 5% 2-mercaptoethanol, 0.05% bromophenol blue, and 10% glycerol by 
boil ing at 100°C for 5 minutes. Fifteen microliters of each denatured sample (10 µg 
protein) and 10 µI of prestained SOS-PAGE molecular standards (Bio-Rad 
Laboratories, Richmond, CA, USA) were loaded on the gel. The molecular weight 
standard contained 8 proteins with molecular masses of approximately 206, 117, 
79, 48.3, 34.7, 29.3, 21.3, and 7.6kO. Electrophoresis was carried out using a 
vertical mini-gel apparatus, as directed by the manufacture. 
Electrophoretic transfer of the proteins. A mini-trans-blot electrophoretic 
transfer cell (Bio-Rad Laboratories, Richmond, CA, USA) was used following the 
procedures recommended by the manufacture. Viral and cellular proteins, along 
with the molecular weight markers that were separated in the gels, were 
electrophoretically transferred to a 0.45 µm nitrocellulose membrane (B io-Rad 
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Laboratories, Richmond, CA, USA) following SOS-PAGE. Transfer was carried out 
at 4°C for 60 minutes in a transfer buffer (pH 8.3) consisting of 25 mM Tris, 192 mM 
glycine, and 20% (v/v) methanol. Nitrocellulose membranes containing viral and 
control cellular antigens were blocked overnight at 4°C with 1 % bovine serum 
albumin dissolved in Tris-buffer saline (TBS, pH 7.5) containing 500 mM NaCl and 
20 mM Tris. 
Western immunoblotting. Blocked membranes were washed twice for 5 
minutes each in gently agitating TBS and cut into strips containing viral antigens, 
cellular antigens, and molecular weight standards. Serum samples to be tested 
were diluted 1 :50 in TBS containing 0.05% Tween 20 (TTBS) and 1 % bovine serum 
albumin. Sera collected from pigs on the day of inoculation served as negative 
controls. Each diluted serum sample was added to the single membrane strip and 
incubated for 1 hour at room temperature. Following incubation, the membranes 
were washed 3 times in TTBS by gently agitating for 5 minutes each. Antigen -
antibody reactions were visualized with diluted goat anti-swine lgG (H+L) labeled 
with horseradish peroxide and TMB membrane peroxide substrate (Kirkegard and 
Perry Laboratories, Inc., Giathersburg, MD, USA). The color reaction was stopped 
by brief washes in deionized water. The appearance of virus-specific reactivity was 
assessed by comparing the antibody responses to the vira l and cellular antigens. 
Histopathology. Tissues were collected and fixed by immersion in 10% neutral 
buffered formal in. Fixed tissues were processed, embedded, and sectioned 
following standard procedures. Each section was then stained with hematoxylin 
and eosin. 
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lmmunohistochemistry and in situ hybridization. Tonsil, liver, ileum, kidney, 
lung, medial iliac lymph node, thymus, and spleen were collected from each pig, 
fixed in 10% neutral buffered formalin, and tested for the presence of nucleic acid 
and antigens of PCV-2 by ISH and IHC, respectively. The ISH was performed using 
fluorescein-labeled sense and antisense RNA probes specific for ORF1 of PCV-2 
(ISU-31 ), as previously described (21 ). In brief, tissue sections (5 µm thick) were 
deparafinized, rehydrated, and treated with proteinase K (50 µg/ml). Before 
hybridization, sections were incubated with 200 µI of hybridization buffer using a 
CoverWell® chamber (Grace Bio-Labs, Bend, OR) at 95°C for 10 minutes. Sections 
were hybridized with the RNA probes, washed, and treated with RNase A. The 
presence of PCV-2 nucleic acid was visualized by incubating each section with anti-
fluorescein alkaline phosphatase and then 4-nitro-blue tetrazolium and 5-bromo-4-
chloro-3-indolyphosphate (Boehringer Mannheim, Indianapolis, IN). Sections were 
counter stained with nuclear fast red prior to microscopic examination. 
The IHC was performed using hyperimmune rabbit anti-PCV-2 serum raised 
against highly purified ISU-31 isolate of PCV-2, as described elsewhere (24). In 
brief, tissue sections (4 µm thick) were deparafinized, rehydrated, and treated with 
proteinase K. Each section was incubated with optimally diluted PCV-2 antiserum. 
Antigen-antibody complexes were visualized using a biotin-strepavidin-
diaminobenzidine system, DAKO LSAB2® kit (DAKO Corporation, Carpinteria, CA). 
Sections were counter stained with Gill's hematoxylin (Fisher Scientific, Pittsburgh, 
PA). 
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Statistical analysis. Differences in serologic responses among isolates of 
PCV-2 and PCV-1 in the IFA and VN tests were evaluated using the analysis of 
variance and Duncan's multiple range test. 
RESULTS 
No clinical signs resembling those described for PMWS were observed after 
experimental inoculation. All inoculated pigs remained normal in their appearance 
and behavior throughout the study period. As determined by the detection of PCV-2 
DNA in serum by PCR, all pigs became viremic after inoculation (F igure 2) . Viremia 
was detected in all pigs on days 7 and 14 Pl and in 2 of 5 pigs on day 21 Pl. No 
pigs were viremic on day 28 Pl. No PCV-1 was detected by PCR in the serum of 
any of the 5 pigs during the study period. 
The humeral immune response of the pigs to PCV-2 is summarized in Figure 3. 
Two weeks prior to and on the day of challenge, none of the 5 pigs had detectable 
antibody against either PCV-2 or PCV-1 as measured by IFA and VN tests. After 
challenge all pigs seroconverted to PCV-2. Virus-specific lgG antibody was initially 
detected by IFA at 14 days Pl (1 :80 to 1 :640). Antibody levels continued to 
increase and by the end of the study the mean antibody titer was 1: 1792 with a 
range of 1: 1280 to 1 :2560. Day 35 serum samples were also assayed by IFA using 
4 other field isolates of PCV-2 in the test system. No significant difference in 
antibody titers to individual isolates was observed when compared to that against 
the homologous isolate (p>0.01 ). 
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Figure 2. Detection of cell-free viremia of PCV-2 in 5 experimentally infected 
pigs by a multiplex polymerase chain reaction . Lane 1: 100-bp DNA ladder; A-E: 
sera collected at day 0, 14, 21, and 28 post inoculation, respectively; Last 3 lanes 
are negative control , PCV-2 positive control , and PCV-1 positive control , 
respectively. 
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Figure 3. Antibody responses of 5 COCO pigs to PCV-2 infection as determined 
by indirect fluorescent antibody (IFA) test(•) and virus neutralization (VN) test(_.). 
Serum samples were also tested by IFA test for antibody cross-reactive to PCV-1 
(v ). Each point represents mean± SEM. 
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Antibody titers against the 4 field isolates ranged from 1: 1280 to 1 :2560. 
Neutralizing antibody against PCV-2 was first detected on day 28 and on day 35 the 
mean VN titer was 1 :8.8. Using sera collected on day 35, no significant difference in 
susceptibility to neutralization was observed among the 4 additional PCV-2 isolates. 
As neutralizing antibody to PCV-2 appeared, cross-reactivity with PCV-1 was also 
detected by IFA in all pigs. However, IFA antibody titers to PCV-1 ranged from 
1: 160 to 1: 320 and were significantly lower than IFA antibody titers to PCV-2 
(p<0.01 ). No virus neutralization against PCV-1 was detected either. 
No antibody to other significant swine viral pathogens was detected throughout 
the study period, including CSFV, HEV, PCMV, PEV, PPV, PRRSV, PRV, SIV, and 
TGEV. 
Under reducing conditions, 3 polypeptides with molecular masses estimated at 
28, 28.5, and 35kD were demonstrated in PCV-2 using day 35 serum samples as a 
source of antibody (Figure 4A). The antibody response indicated that the 35kD 
protein was associated with PCV-1, as well. The temporal viral protein specificity of 
the immune response was also characterized by western immunoblot analysis 
(Figure 4B). Antibodies reactive to the 28kD protein were first detected in pigs at 14 
days Pl and antibodies to the 28.5kD and 35kD proteins were detected on day 21 
Pl. Once antibody to each viral polypeptide had appeared , it persisted to the end of 
the study. 
At necropsy (35 days Pl) , no gross lesions were observed in any of the 5 pigs. 
Microscopically, livers from all pigs had small foci of individual hepatocyte necrosis 
associated with aggregates of lymphocytes and plasma cells. In addition, apparent 
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Figure 4. Representative western immunoblot analysis of the antibody 
response of pigs to PCV. Panel A is a photograph showing the temporal viral 
protein specificity of antibody responses of 5 pigs to PCV-2 infection using pooled 
sera from the pigs on days 7 (lane 1 ), 14 (lane 2) , 21 (lane 3) and 28 (lane 4) post 
inoculation. Panel B illustrates the reactivity of antibodies in pooled sera that were 
collected from PCV-2 infected pigs on day 28 Pl to PCV-1 (lane 2) , negative control 
cell (lane 3), and PCV-2 (lane 4) antigens. Lanes 1 and 5 are protein molecular 
weight markers. 
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mild depletion of lymphoid follicles was observed in tonsil , spleen, and Peyer's 
patch of the ileum. Lungs and other tissues examined were unremarkable. In 4 of 
the 5 pigs, the viral genome and viral antigens were detected by ISH and IHC, 
respectively, in the tonsil, Peyer's patches of the ileum, and medial il iac lymph 
nodes (Figure 5) . 
Figure 5. Photomicrographs of tonsil (A, B) and lymph node (C, D) collected on day 
35 post inoculation from one of 5 pigs experimentally infected with PCV-2 in which 
the virus was detected by in situ hybridization (A, B) and immunohistochemistry (C, 
D), respectively. 
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DISCUSSION 
The goal of this study was to assess the immunological response of naive pigs 
to PCV-2 infection under experimental conditions. After inoculation, PCV-2 viremia 
was apparent through day 21. At the termination of the study, the virus was still 
present in various tissues of inoculated pigs in which lymphoid depletion, the 
characteristic microscopic lesion of PMWS, was observed, although the degree of 
depletion was very mild. In addition, mild hepatic lesions, similar to those previously 
reported to be associated with PCV-2 infection, were also observed (8, 11 ). These 
results clearly indicated that naive pigs were susceptible to PCV-2. However, lack 
of clinical signs and remarkable pathologic changes compatible with PMWS suggest 
that, if PCV-2 has a causal role in PMWS, the presence of additional factors may be 
necessary to induce PMWS. This point remains to be clarified. 
Although questions remain as to the pathogenesis of PMWS, this study 
contributed to our basic understanding of virus structure and host response. The 
protein composition of PCV-2 is unknown, but based on an analysis of the viral 
genome, PCV-2 has been postulated to contain as many as 11 ORFs each of which 
could encode for a different polypeptide (9). However, western immunoblot analysis 
in this study demonstrated only 3 viral polypeptides with molecular masses of 28, 
28,5, and 35kD (Figure 4). Of these, the 28 and 35kD proteins matched the 
expected molecular weight of the polypeptides predicted to be encoded by ORFs 1 
and 2 (9, 21) and, on that basis, may be postulated to be the protein products of 
ORF 2 and 1, respectively. Because of the reducing conditions required to prepare 
samples for western immunoblotting, it is possible that viral proteins present in the 
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PCV-2 preparation underwent conformational changes and were no longer 
recognized by antibodies. 
The 28kD protein was the most immunogenic of the 3 proteins identified, based 
on the observation that antibodies specific for this protein appeared first and 
persisted to the end of the study (Figure 4B). Assuming that the intensity of the 
reaction to a protein in western immunoblotting reflects the quantity of antibody in 
serum, levels of antibodies against the 28kD protein in sera at a given dilution were 
always much higher than antibodies to the other two proteins. Furthermore, 
antibody against the 28kD protein was not detected using PCV-1 antigens on 
western immunoblotting. These results suggested that the 28kD protein might 
provide the antigenic basis for the development of diagnostic tests for the detection 
of PCV-2-specific antibody. 
Results of western immunoblot analysis and serological monitoring data 
suggested that the 28.5kD and/or 35kD proteins were associated with the induction 
of neutralizing antibody and the 28kD protein was not. Antibody to the 28kD protein 
was present in all pigs for 2 weeks prior to the initial detection of neutralizing 
antibody. It is not certain whether the 28.5kD protein, the 35kD protein, or both are 
responsible for virus neutralization, but neutralizing activity in sera appeared to 
correlate with the appearance of antibodies to the 35kD protein. As shown in Figure 
4B, the antibody response to the 35kD protein was very weak on day 21 Pl and 
became stronger at day 28 Pl when detectable VN antibody was present. In 
contrast, an intensive reaction was already detected with 28.5kD protein at day 21 
Pl in the absence of detectable neutralizing antibody. Additional research is 
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necessary to define the role of antibodies specific for 28.5kD and 35kD protein in 
viral neutral ization. 
Porcine circovirus type 2 has been reported to be genetically and antigenically 
distinct from PCV-1 (2, 9, 21 ). In this study, marked antigenic differences between 
PCV-1 and PCV-2 were demonstrated on the basis of significant differences in IFA 
antibody titers and antibodies specific for PCV-2 failed to neutralize PCV-1 (Figure 
3) . In addition, western immunoblot analysis demonstrated 3 viral proteins that 
have not been reported in association with PCV-1 . Previously, two immunoreactive 
proteins with a molecular mass of 31 kD and 33kD were reported for PCV-1 (26). 
These proteins however were not detected in this study, either because it was not 
present in PCV-2, or if present, it may have been subjected to conformational 
changes brought about by the reducing conditions necessary for the preparation of 
viral antigens for western immunoblotting . 
Cross reactivity between PCV-1 and PCV-2 in IFA test has been reported (2) . 
Although the data strongly supported significant differences between PCV-1 and 
PCV-2, some degree of serologic cross-reactivity between PCV-1 and PCV-2 was 
demonstrated in the IFA test (Figure 3). At the protein level, antibodies to the 35kD 
protein appeared responsible for the cross-reaction. This conclusion is based on 
the fact that antibody from pigs infected with PCV-2 recognized th is protein in both 
types of PCV on western immunoblotting (Figure 4) . Assuming that the 35kD 
protein is the protein product of ORF1 , our conclusion is also supported by 
sequence analysis data demonstrating high DNA homology in ORF1 between PCV-
1 and PCV-2 (9, 20, 21 ). Previous serological surveys using PK-15 contaminated 
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with PCV, i.e., PCV-1 , demonstrated that PCV infection was common in swine. 
Data from the present study showed that earlier serological surveys would have 
detected antibodies against either PCV-1 or PCV-2. That being the case, PCV-2 
may have been present in the swine population for quite some time and not a recent 
introduction. 
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CASE-CONTROL STUDY ON THE ROLE OF PORCINE CIRCOVIRUS TYPE 2 
AND OTHER MAJOR SWINE VIRUSES IN POSTWEANING MUL TISYSTEMIC 
WASTING SYNDROME 
A paper to be submitted to the Journal of Virology 
Roman M. Pogranichnyy1, Kyoung-Jin Yoon 1, Perry A Harms 1, Steven D. Sarden 1, 
Michael Daniels2 
Abstract 
A field-based case-control study was conducted to assess the strength of 
association of porcine circovirus type 2 (PCV2) and some major swine viruses with 
postweaning multisystemic wasting syndrome (PMWS). Cases were defined as 
individual pigs with a clinical history of progressive weight loss and respiratory signs 
and that were subsequently diagnosed with PMWS on the basis of histopathological 
observations: 1) depletion/atrophy of lymphoid tissue and/or 2) macrophage-
dominated granulomatous inflammation mainly in lymphoid tissues, lung, and 
intestine. Controls were pigs without histopathological lesions characteristic of 
PMWS and/or from herds in which PMWS had not been diagnosed and with no 
clinical signs compatible with PMWS. 
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A total of 31 cases and 56 controls were identified from diagnostic 
submissions or farms within a six-month period. Serum and various tissues were 
collected from all animals and assayed for PCV2, porcine reproductive and 
respiratory syndrome virus (PRRSV), porcine parvovirus, porcine enterovirus (types 
2 and 3) , swine influenza viruses, porcine respiratory coronavirus, transmissible 
gastroenteritis virus, porcine endogenous retrovirus, porcine lymphotropic 
herpesvirus type 1, and bovine viral diarrhea virus. The proportion of case and 
controls pigs positive for each virus was determined and statistically compared to 
determine the strength of the association that each virus had with PMWS. In 
addition, PCV2 isolates from 6 cases and 4 controls were selected and genetically 
compared. Type 2 PCV appeared to be strongly associated with PMWS (odd ratio 
= 9.3) as compared to other viral agents tested for. Risk for PWMS was much 
higher if the animal was concurrently infected with PCV2 and PRRSV (odd ratio= 
31.2). However, PCV2 was also found in many controls (35/56) and was not 
detected in 2 of the 31 PMWS pigs. Furthermore, no significant genetic difference 
was observed between PCV2 isolates from PMWS and control pigs, indicating that 
the difference in virulence, if any, may not be associated with viral genetic trait. 
Therefore, causal role of PCV2 in PMWS is in question. Development of PMWS 
may require co-factor(s) in addition to PCV2. Further work remains to determine 
the actual role of PCV2 in PMWS and the pathogenesis of PCV2 infection. 
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INTRODUCTION 
Postweaning multisystemic wasting syndrome (PMWS) is an emerging 
problem of growing pigs worldwide (1 O; 17). The syndrome is characterized by 
progressive weight loss in pigs at 4-16 weeks of age. Other common clinical 
symptoms are respiratory signs, such as tachypnea and dyspnea, icterus, and 
diarrhea ( 17). Pathological changes have been observed in lymphoid organs and 
lungs of affected pigs. A consistent histopathological finding is the depletion of 
lymphocytes and replacement with macrophages in the B- and T-cell-dependent 
areas of all lymphoid tissues. Other common microscopic changes include 
lymphocytic to granulomatous interstitial pneumonia, lymphadenopathy, and less 
frequently lymphocytic granulomatous hepatitis and nephritis (6; 1 O; 14;36). The 
PMWS was first recognized in Canada in 1991 as a chronic, insidious and 
sometimes protracted disease (10;17). Although the etiology of the syndrome is not 
completely elucidated to date, isolation or detection of circovirus which is genetically 
and antigenically distinct from PCV originally found in PK-15 cell line as 
noncytopathic viral contaminant, is reportedly associated with PMWS (6;14). To 
reflect the significant genetic and antigenic difference between these two 
circoviruses, the circovirus isolated from pigs affected by PMWS has been 
designated PCV type 2 (PCV2) (2;30) . Genome and/or antigens of PCV2 have been 
detected within and around lesions in tissues, such as tonsil , multiple lymph nodes, 
spleen, Peyer's patches, bone marrow, small intestine, kidney, and lung, from pigs 
affected by PMWS (36) . 
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Although PCV2 is postulated to be the causative agent for PMWS, there are 
several reports suggesting that PCV2 may not be the only agent causing PMWS. 
PCV infection in swine herds with and without clinical disease compatible to PMWS 
has been documented through sero-epidemiological studies, suggesting that PCV is 
ubiquitous. (5; 12;25;43) Despite of its apparent ubiquity, the incidence of PMWS in 
a given herd is considerably low, 5-15% (38). There are no published reports 
documenting clinical disease and pathological changes in conventionally raised pigs 
which were experimentally infected with PCV2 only, although the virus is 
demonstrated to be infectious for na"i"ve swine based on virus isolation/detection in 
various tissues and seroconvertion (3; 15;23;34) . In addition, pathological changes 
compatible with lesions described in field cases have been experimentally 
reproduced only in pigs concurrently infected with PCV2 and porcine parvovirus 
(3;7;23;29). It has been speculated that there is the involvement of 
immunosuppressive agents, management problems, or environmental factors in the 
development of PMWS (14) . Therefore, the causal role of PCV2 in PMWS has not 
been conclusively demonstrated. 
The following case-control study was conducted to evaluate the relative 
importance of PCV2 and some major swine viral agents in PMWS and determine if 
genetic trait of PCV2 is associated with its pathogenicity. In part, diagnostic 
performance of different laboratory tests in detecting PCV2 and its value for PMWS 
diagnosis was also evaluated. 
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MATERIALS AND METHODS 
Experimental design 
The investigation was a field-based case-control study. Cases were pigs at 
4 to16 weeks of age with clinical signs of PMWS (i.e. , progressive weight loss, 
respiratory disease) on farm and later diagnosed as PMWS based on the presence 
of characteristic histopathological lesions: 1) some degree of depletion/atrophy of 
lymphoid tissue and/or 2) macrophage-dominated granulomatous inflammation in 
any tissue, but especially lymphoid tissue, lung, and intestine. Controls were pigs at 
4 to 16 weeks of age without PMWS and/or from herds in which PMWS had not 
been diagnosed and no cl inical manifestations described for PMWS were present, 
or sick pigs submitted with completely unrelated clinical history to the Iowa State 
University Veterinary Diagnostic Laboratory (ISU-VDL) for diagnostic evaluation. A 
total of 31 cases and 56 controls were identified within a six-month period and used 
for the study. Serum and various postmortem tissues (tonsil , spleen, lymph nodes, 
lung, liver, and ileum) were collected from each pig and stored frozen at -80°C until 
tested. Clinical specimens were assayed by virus isolation (VI) , 
immunohistochemistry (IHC), and/or polymerase chain reaction (PCR) for PCV2 
and other viral agents such as porcine reproductive and respiratory syndrome virus 
(PRRSV), porcine parvovirus (PPV), porcine enterovirus types 2 and 3 (PEV), swine 
influenza virus (SIV) , porcine respiratory coronavirus (PRCV), transmissible 
gastroenteritis virus (TGEV), porcine endogenous retrovirus (PERV), porcine 
lymphotropic herpesvirus type 1 (PLHV-1 ), and bovine viral diarrhea virus (BVDV). 
Appropriate serologic assays were performed to determine the presence and 
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absence of antibody against some of these viruses. The proportion of pigs 
virologically and/or serologically positive for each virus was determined for case and 
control groups and statistically compared to determine the strength of the 
association that each viral agent had with PMWS individually or in combination. In 
addition, PCV2 isolates from 6 cases and 4 controls were selected. The entire 
genome of each isolate was sequenced and compared each other to identify 
genetic marker(s) unique to PCV2 from PMWS cases. The agreement of various 
laboratory diagnostic tests in detecting PCV2 was also evaluated, as well as 
diagnostic performance (i .e., sensitivity, specificity) of each test. 
Virus isolation (VI) 
Virus isolations were attempted on clinical specimens for PCV2 and PRRSV 
as described elsewhere (6;22;34). A continuous porcine kidney cell line PK-15 free 
of PCV1 and MARC145 clone of African Green Monkey kidney cell line (22;45) 
were used for virus isolation as indicator system for PCV2 and PRRSV, 
respectively. For better recovery of PCV2 from clinical specimens, PK-15 cells 
were treated with D-glucosamine as previously described (42). Samples were 
considered negative for these two viruses after two blind passages. At the end of 
each passage, the absence of virus in cells was confirmed by immunofluorescence 
microscopy using appropriate polyclonal or monoclonal antibody specific for each 
virus. 
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Polymerase chain reaction (PCR) assays 
Various PCR-based assays were used to detect nucleic acids of PCV2 and 
other viruses in specimens. A multiplex PCR was used for specific detection of 
PCV2 DNA as previously described (34) . Reverse transcription (RT)-PCR assays 
were used for detecting RNA of PRRSV (46), BVDV (35), PERV (1) and PEV (47). 
Swine influenza virus or TGEV/PRCV genome in samples was detected using 
m.ultiplex RT-PCR assays established in ISU-VDL (19) ; PCR-based assays 
described by (31) and (13;15) were employed for detecting DNA of PPV and PLHV-
1, respectively. In brief, viral DNA or RNA was extracted from 0.2ml of each sample 
using QIAamp® Tissue Kit (Qiagen, Santa Clarita , CA) as recommended by the 
manufacturer. Two µI of each extract was used for amplification. In each assay, 
virus or virus infected cells and mock-infected cells were included as positive and 
negative controls, respectively. The presence of target sequence in samples was 
visualized by an agarose (1 .5%, FMC NuSieve 3: 1) gel electrophoresis of PCR 
amplicon with 100-bp DNA ladders (GIBCO/BRL, Grand Island, NY, USA) and 
molecular size determination. PCR primers for each viral agent and detailed 
thermocycling conditions can be found in references cited previously. 
Histopathology and lmmunohistochemistry (IHC) 
Tissues (tonsil , liver, ileum, kidney, medial iliac lymph node, lung) were fixed 
by immersion in 10% neutral buffered formalin immediately after collected. Fixed 
tissues were processed, embedded, and sectioned following procedures 
established in ISU-VDL. Each section was then stained with hematoxylin and 
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eosin.The IHC for detecting PCV in tissues was performed using hyperimmune 
rabbit anti-PCV-2 serum raised against a PCV-2 isolate as described elsewhere 
(39) . In brief, tissue sections (4 µm thick) were deparafinized, rehydrated , and 
treated with proteinase K. Each section was incubated with optimally diluted PCV-2 
antiserum. Antigen-antibody complexes were visualized using a biotin-strepavidin-
diaminobenzidine system, •AKO LSAB2® kit (•AKO Corporation, Carpinteria, CA). 
Sections were counter stained with Gill's hematoxylin (Fisher Scientific, Pittsburgh, 
PA). 
Serology 
Various serological assays were performed to determine the presence and 
titer of antibodies to PCV, PPV, PRRSV, SIV, TGEV, and BVDV. Antibody specific 
for PCV was assessed using an indirect fluorescent antibody (IFA) test as 
previously described (34). PRRSV antibodies were measured by a commercial 
ELISA kit using the procedure recommended by the manufacturer. 
Hemagglutination inhibition (HI) test was employed to assess antibodies against 
PPV and SIV (both H1 N1 and H3N2 subtypes). Serum virus neutralization (SVN) 
tests were used to detect antibodies to BVDV (types 1 and 2) and TGEV/PRCV. 
Hemagglutination inhibition and SVN tests were conducted using protocols 
established in ISU-VDL. 
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Sequence analysis of PCV2 
Total DNA was extracted from a homogenate of mixed tissues (tonsil , 
spleen, lymph nodes, lung, liver, and small intestine) from each of selected animals 
using DNA QIAamp® Tissue Kit (Qiagen Inc. Valenica, CA, USA) according to 
protocol recommended by the manufacturer. The genomic DNA of PCV2 was 
amplified by PCR using 2 sets of overlapping primers that were designed using the 
sequence data in GenBank (AF147751 ). PCR products were purified using a PCR 
purification kit QIAquick® (Qiagen Inc. Valenica, CA, USA) according to 
manufacturer's protocol. Two overlapping products from two separate PCR 
reactions were sequenced using a automated sequencer model ABl377™ (Applied 
Biosystems, Forest City, CA, USA) at the ISU Nucleic Acid Facility. Sequence data 
were then proofread, aligned and analyzed using computer software, DNAStar™ 
(DNASTAR, lnc.Medison, WI , USA). PCR and sequencing primers are summarized 
in Table 1. 
Statistical analysis 
The distribution of PCV or other virus positives among cases and controls 
was evaluated statistically using Chi square test. Spearman's rank correlation 
between agents was assessed to determine if there was any potential 
multicollinearlity type problem if particular agents were highly correlated with each 
other, i.e. , one agent was always present with another (11 ). Association of more 
than one agent with PMWS was determined by logistic regression analysis (9) . If 
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Table 1. PCR and sequencing primers for sequencing the whole genome of 
porcine circovirus type 2 
Use 
PCR primers: 
Sequencing primers: 
Designation Nucleotide sequence (5' - 3') 
C931 F AAGGGGGCCAGTTCGTCACC 
C268R 
C22F 
C1718R 
C22 
C471 
C931 
C1718 
C808 
C511 
C1488 
C268 
C1266 
AGCGGGCACCCAAATACCACTTCA 
CAGCACCTCGGCAGCACCTCAG 
TACAATCCCCCAACCCTTCTCCTG 
CAGCACCTCGGCAGCACCTCAG 
CAGCACCTCGGCAGCACCTCAG 
AAGGGGGCCAGTTCGTCACC 
TACAATCCCCCAACCCTTCTCCTG 
AACGGGGTCTGATTGCTGGTAA 
TCTGCATTTTCCCGCTCACTTTCA 
CCCGGGGGAACAAAGTCGTCAATA 
AGCGGGCACCCAAATACCACTTCA 
AATCCCCCAACCCTTCTCCTACCA 
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the distribution was statistical ly significant, the strength of the association between 
PMWS and and individual virus was determined by calculating odds ratio. 
RESULTS 
The significance of PCV2 and several other viral pathogens (i .e., PRRSV, 
PPV, PEV, SIV, TGEV, PRCV, PLHV-1, PERV, BVDV) relative to development of 
PMWS was assessed using a case-control study design. The proportion of animals 
in each group, which were positive for an individual virus, is illustrated in Figure 1. 
Regardless of an individual animal's clinical status, all animals tested (N=93) were 
positive by RT-PCR for PERV, demonstrating that endogenous retrovirus is 
ubiquitous in swine. Besides retrovirus, PCV2 was the next most common viral 
agent detected in this study. Using various virological assays (VI , IHC, PCR), 29 of 
31 PMWS pigs (93.5%) were positive for PCV2, whereas the virus was found in 35 
of 56 control pigs (64%). Interestingly, PCV2 was not detected by any virological 
means in 2 of the 31 pigs affected by PMWS. On the other hand, these 2 pigs were 
positive for PRRSV, PLHV-1, and PERV. Fifty eight percent of PMWS and 18% and 
control pigs, were considered to be viremic at the time of sampling as PCV2 DNA 
was detected in their serum; however, no infectious virus was isolated from any of 
these pigs except one PMWS pig (Figure 2) . Serologically all these animals had 
relatively high titers of IFA antibodies to PCV2, which failure of isolating PCV2 from 
sera may be attributed to. It is also worthwhile to note that PCV1, nonpathogenic 
strain, was also detected but only in control pigs (2%) . In addition to PCV2, other 
viruses except TGEV and BVDV were detected in varying proportions of animals 
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examined (Figure 1 ). However, animals positive for these viruses except PRRSV 
were almost equally distributed between case and control pigs, suggesting that 
infection of PPV, PEV, SIV, PRCV, or PLHV-1 is virtually insignificant relative to 
PMWS (p>0.05). In contrast, PRRSV was present in 42% and 20% of PMWS and 
control animals, respectively, suggesting that the virus has some association with 
PMWS. Statistically, PCV2 as single entity was the most strongly associated with 
PMWS among viruses tested and the odd ratio was 9.3 (95% Cl = 1.9, 45.3). That 
is, animals with PCV2 have 9.3 times higher risk for PMWS as compared to animals 
without PCV2. In comparison, pigs infected with PRRSV had odd ratio of 3.4 (1 .2 ~ 
95%CI ~ 9.8) developing PMWS, which was considered significant (p=0.027) as 
compared to pigs without PRRSV infection. However, the risk for PMWS was much 
higher in pigs infected with both PCV2 and PRRSV (odd ratio= 31.2, 4.1 ~ 95%CI 
~238, p=0.009). Such a significantly increased risk for PMWS was not observed in 
combination of PCV2 and other viruses or in combination of other viruses each 
other (p>0.3). 
Genetic analysis of selected PCV2 from case and control pigs is summarized 
in Figure 3. Sequence homology among PCV2 from the same group was 98.9% for 
cases and 99.1 % for controls. Comparison of linear nucleotide sequence did not 
reveal significant difference in genomic sequences between PCV2 from clinical 
cases of PMWS and these ones from control pigs. Overall identity of nucleotide 
sequences among all PCV2 isolates compared was 99%. Virtually, sequence 
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63 
motifs of non-coding region for virus replication (27) remained unchanged in all 10 
isolates. Divergence in coding regions between PCV2 from cases and from 
controls was 0.7% at the nucleotide level and 2.4% at the deduced amino acid level. 
A phylogenetic analysis also did not demonstrate significant genetic differences 
between PCV2 from control pigs in this study and PCV2 isolates from clinical 
PMWS cases previously reported by other investigators. However, it is worthwhile 
to note that genetic distance was more close each other among North American 
PCV2 than to European ones. 
Diagnostic performance of several laboratory assays (VI, IHC, PCR, IFA) 
developed to detect PCV2 or its infection were evaluated and summarized in 
Figures 4. Using disease status of animals (i.e., PMWS versus non-PMWS) as 
refference test, IHC showed the best overall performance in detecting PCV2 in 
association with PMWS. The diagnostic sensitivity and diagnostic specificity of IHC 
was estimated to be 80% and 91 %, respectively. In contrast, PCR had the 
sensitivity of 90% but showed poor specificity (39%) with respect to detecting 
PMWS pigs. However, PCR results were in better agreement with serological 
results (kappa= 0.516) as compared to degree of agreement between IHC and IFA 
(kappa =0.11 ), suggesting that PCR-based assay performs better than other tests in 
detecting PCV2 in animals regardless of their clinical status related to PMWS 
(Figure 4). For detecting PCV2 or viral antigens, tissues, particularly secondary 
lymphoid tissues were better than serum. 
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DISCUSSION 
Porcine circovirus type2 is a newly recognized virus in the swine population and has 
been isolated and/or detected from clinical specimens of pigs diagnosed with 
PMWS (4;14;26;32). Despite diagnostic information strongly suggest that PCV2 is 
the causative agent of PMWS, experimental animal trials with PCV2 only, including 
the previous study in our laboratory have reproduced at best mild microscopic 
changes somewhat compatible with ones described in pigs affected with PMWS 
(3; 18;23;34 ). Nevertheless no "wasting syndrome" has been reproduced even in 
immunocompromised animals. It raised the question of whether other factors 
besides PCV2 should be involved for PMWS if PCV2 plays primary role in PMWS. 
Concurrent infections with other agents, suboptimal management, and 
environmental stress have been suggested as potential co-factors. Experimentally, 
histopathological lesions typically observed in pigs affected by PMWS were 
reproduced in pigs accidentally or intentionally infected concurrently with PCV2 and 
porcine parvovirus (3;23;29). However all these animal trials failed to reproduce the 
disease. Therefore, the main objective of the case-control study was to assess the 
role of PCV2 alone and in conjunction with other major swine viral agents in PMWS 
in growing pigs in Iowa. 
Our case-control study revealed that PCV2 as single entity had stronger 
association with PMWS (odd ratio= 9.3, 1.9:::; 95%CI ::;45.3) than other viral agents 
tested, which is in general agreement with previous reports by other investigators 
(16;37) . However, PCV2 was also found in approximately 63% of pigs clinically 
normal or with clinical signs and pathological findings irrelevant to PMWS. 
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Furthermore, the virus was not detected in 2 of the 31 pigs (6.5%) that did not thrive 
well and had histopathological lesions typical of PMWS. These observations raised 
the question of why the majority of animals proven to be infected with PCV2 were 
clinically and pathologically silent related to PMWS. Furthermore, although the risk 
for PMWS was shown to be higher in pigs infected with PCV2 than pigs without 
PCV2 infection, the estimated odd ratio of 9.3 (95% Cl= 1.9, 45.3) is relatively low, 
i.e., strength of association is weak, if PCV2 infection is considered to be the 
causality of PMWS. In comparison, PRRSV infection showed odd ratio of 11 .2 
when PRRS emerged as mystery swine disease (48). Consequently, our data 
suggest that other factors besides PCV2 may be required for development of 
PMWS in pigs if PCV2 can predispose pigs to PMWS. One of several possible co-
factors is synergistic effect of other viral agents. In this regard, several major swine 
viral pathogens, such as PRRSV, parvovirus, influenza virus, coronavirus and 
enterovirus, were examined in this study. Apparently, the risk for PMWS was 
dramatically increased if animal was co-infected with PRRSV (odd ratio =31.2, 4.1 ~ 
95%CI ~238), suggesting that concurrent infection of PRRSV contributes to 
development of PMWS in pigs infected with PCV2. Experimentally, it was reported 
that cesarean-derived colostrum-deprived animals were icteric, wasted, and died of 
increased severity of disease when infected with PCV2 and PRRSV (20). A higher 
risk for PMWS by concurrent infection of PCV2 and PRRSV is not unexpected 
result since PRRSV is known to be prevalent in Iowa swine. Practically, this 
observation suggests that the risk for PMWS and the severity of disease could be 
reduced by better control of PRRSV. Nevertheless, it remains to be answered why 
67 
13% of control pigs that were infected concurrently with PCV2 and PRRSV did not 
develop PMWS if co-infection with PRRSV would be critical for PMWS. 
Such an increasing risk for PMWS was not observed with other swine viral 
pathogens such as parvovirus, enteroviruses, influenza virus, and coronaviruses 
(p>0.3) . In particular, it was in contrast to previous reports (16) that no significant 
potentiation for PMWS was observed in pigs concurrently infected with PCV2 and 
PPV. In our study, very few pigs were determined to have parvovirus at the time of 
sample collection. It may have been attributed to the fact that our study used 
conventionally raised pigs which are considered to be immunologically competent 
and most of which had PPV antibodies that appeared to be of colostrum origin. If 
any of the viruses described above has any positive effect on development of 
PMWS, the order and timing of infection would attribute to the difference in 
outcome, which remains to be further studied. Besides common swine viral 
pathogens, viral agents that are capable of affecting the immune system of pigs 
were also evaluated in the present study, including retrovirus, herpesvirus, and 
BVDV (1 ;13;44). These viruses are known to replicate in porcine cells of the 
immune system and dysfunction or suppress the immunity or lymphoid proliferation 
of the pigs. Such a condition was postulated to be required for extensive replication 
of PCV2 in pigs (3). In our study, all pigs examined were positive for nucleic acid of 
porcine endogenous retrovirus (PERV), indicating that endogenous retrovirus is 
ubiquitous in swine. Since its distribution between PMWS and control pigs was 
even, PERV would not be considered to contribute to PMWS. Porcine lymphotropic 
herpesvirus type 1 is a gamma herpesvirus recently identified in pigs (13). The virus 
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was speculated to be avirulent to swine (13). In agreement with previous report, our 
study did not reveal the significant role of PLHV-1 in development of PMWS. 
However, it is worthwhile to note that the virus appears to be widespread in U.S. 
domestic swine as detected in 41 % of pigs tested in our study. PLHV-1 is 
considered to pose the potential risk for disease in immunocompromised human 
receiving xenotransplant of pig origin. Bovine viral diarrhea virus is known to 
replicate in and destroy subpopulation of lymphocytes in the ruminant (21 ;33) and in 
pigs (44). Recently it was reported that BVDV infection can enhance the virulence of 
other viruses like TGEV in pigs with very similar lesions reported for PMWS: 
generalized lymphocyte depletion throughout the lymphatic system and villous 
atrophy in the intestinal tract (40;44). It has also been reported that contamination 
of cell cultures with BVDV through fetal bovine serum is common (8). Consequently, 
it is possible that some of attenuated or modified lived virus vaccines may contain 
BVDV. Despite the strong possibility that BVDV can be present in pigs, none of 
pigs tested in our study had virological or serological evidence of BVDV infection, 
demonstrating no association with PMWS. Another factor possibly contributing to 
different outcome of PCV2 infection is the variability in the pathogenicity among 
PCV2. Such a possibility was evaluated indirectly using sequence analysis of the 
entire genome of the virus. Based on linear nucleotide sequence, no significant 
genetic differences were observed among PCV2 from PMWS and clinically normal 
pigs (Figure 3). Overall sequence homology among PCV2 regardless of their 
source was approximately 99%. Furthermore, no genetic change/marker that is 
unique to PCV2 from the same clinical status group (i .e., PMWS versus control was 
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observed either. Since virus in clinical specimens were directly compared by PCR 
amplification and sequencing to avoid any selective pressure during in-vitro cell 
culture, our observations indicate that apparent differences in virulence, if any, may 
not be associated with genetic traits of the virus. However, potential differences in 
the pathogenicity needs to be studied using a biological system, i.e. , animal trial, 
prior to coming to the conclusion on this. In addition, the difference among PCV2 
should be investigated at the gene expression level. All laboratory procedures 
developed for detecting PCV2 or its infection, such as virus isolation, PCR, IHC and 
serology, are known to be specific (5; 15;24;28;34;39;41 ). All tests are also 
considered to have reasonable sensitivity for detecting PCV2 in clinical cases; 
however, there has been no report comparing the diagnostic performance of 
available PCV2 tests. In this study, several laboratory procedures for PCV 
diagnosis were compared. Using disease status of animals (i. e., PMWS versus 
non-PMWS) as refference test, IHC for PCV showed a good predictive value for 
diagnosing PMWS. Virus isolation results were in a good agreement with IHC 
results (kappa= 0,445). Interestingly, PCR showed diagnostic sensitivity and 
diagnostic specificity of 90% and 39%, respectively, in conjunction with diagnosing 
PMWS pigs, suggesting that PCR may result in a lot of "false" positives. However, 
the trend of higher PCV2 positive rate by PCR was the same in both PMWS and 
control pigs (Figure 2). In addition, PCR results were highly correlated with IFA 
results (kappa = 0.516) as compared to the degree of agreement between IHC and 
IFA (kappa= 0.11 ). These observations indicate that PCR test should be 
considered the most sensitive test among laboratory tests for detecting PCV2 as 
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illustrated in Figure 4. Yet, positive PCR results for PCV2 may need careful 
interpretation because of its apparently low predictive value for PMWS. Since our 
investigation was an observational study, causality of disease could not be 
determined. Yet, a case-control study is an easy and fast approach to determine 
the strength of association that a target organism has with the problem of concern. 
Based on difference in percent positives between cases and controls, PCV2 tends 
to be highly associated with PMWS as compared to other viral agents evaluated in 
this study. At the same time, PCV2 appears to be highly prevalent in swine 
regardless of clinical status of animals as more than 60% of animals without 
apparent clinical signs and pathological changes related to PMWS harbor the virus. 
At the infectious disease point of view, these observations suggest that PCV2 may 
be a bystander of PMWS. Such an observation raises then the question of what 
makes the difference in outcome of infection if PCV2 should be considered as the 
primary cause of PMWS. Apparently, such a difference was not attributed to 
genotype of PCV2 since no significant genetic difference was found among PCV2 
from PMWS and clinical normal pigs. Although concurrent infection with PRRSV 
increased the risk for PMWS dramatically, other viral agents whose infection may 
have similar effect on pigs failed to demonstrate the same effect. Consequently, it 
is hard to make an absolute connection between PCV2 infection alone or 
concurrent infections and development of PMWS. Collectively, the causality of 
PMWS remains to be determined. Furthermore, the actual role and pathogenesis of 
PCV2 in PMWS remains to be re-evaluated. 
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GENERAL DISCUSSION 
Introduction 
Porcine circovirus that is genetically (59) and antigenically (1) distinct from 
PCV found in PK-15 cell line (PCV1 ), has been frequently isolated from or detected 
in growing pigs affected by severe "wasting" syndrome which leaded to the death of 
affected animals in so-called "high-health" status herds. The syndrome was named 
Postweaning Multisystemic Wasting Syndrome (PMWS) after its characteristic 
clinical manifestation. To reflect the difference between two porcine circoviruses, 
isolates from PMWS case were designated PCV2 and PK-15 contaminant PCV1. 
Although diagnostic information highly suggested that PCV2 is associated with 
PMWS (4;22;33), some experimental animal trials failed to reproduce the disease or 
pathological changes in pigs inoculated with PCV2 (42;75). That is, Koch's 
postulates have not been fulfilled. The purpose of this study was to characterize the 
response of pigs to PCV2 infection and evaluate the role of porcine circovirus in 
PMWS. 
PCV2 infection in pigs 
The preceding study demonstrated that na'fve young pigs are susceptible to 
PCV2. Inoculated pigs became viremic and developed a virus-specific antibody 
response. Furthermore, viral DNA and antigens were detected in tissues. 
However, no clinical signs or gross pathological changes were observed in any of 
inoculated pigs during the study but only very mild histopathological changes, 
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suggesting that PCV2 or the isolate used may not be pathogenic for swine or 
additional condition(s) may be required for PMWS. A case-control study was 
conducted to clarify such inconclusive observations from the animal trial. 
Statistically, PCV2 was demonstrated to be highly associated with PMWS (odd ratio 
= 9.3, p=0.005) as compared to other major swine viral pathogens tested for. Risk 
for PWMS was much higher if an animal was co-infected with porcine reproductive 
and respiratory syndrome virus (odd ratio =31 .2, p =0.0009). However, PCV2 was 
also found in a high proportion of clinically unaffected animals and was not detected 
in a few of pigs affected by PMWS. Furthermore, no significant genetic differences 
were observed between PCV2 isolates from PMWS and clinically normal pigs, 
suggesting that differences in pathogenicity among PCV2 isolates, if any, should not 
be attributed to genetic traits of the virus. Collectively, the causal role of PCV2 in 
PMWS is in question. If PCV2 should have a causal role in PMWS, the presence of 
additional factor(s) or condition(s) that were not be assessed in this study may be 
required to induce PMWS, which remains to be clarified . 
Causes of "wasting" disease and lymphoid depletion 
Progressive weight loss is cardinal clinical sign observed in pigs affected by 
PMWS. Microscopically, lymphoid depletion and granulomatous inflammation are 
known to be characteristic lesions in PMWS pigs. However, other conditions have 
been known to cause similar changes in pigs as described for PMWS, which need 
to be taken into consideration in any future studies. For example, lymphoid 
depletion can be induced by infections with Toxoplasma spp. (10), Tchothencene 
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toxin T-2 ( 110), hog cholera (93) , African swine fever (76), steroids (89) and BVD 
(112). 
"Wasting" disease can be caused by many pathogens, such as PRRSV, 
hemagglutinating encephalomyelitis virus, influenza virus, Lawsonia intracelluraris, 
Mycoplasma hyopnemonia, Haemophilus parasuis, Mycobacterium avium-
intracellulare, Colibacteriodis, and Criptosporidosis (33) . In addition, any conditions 
that interfere with normal development of thymus during the fetal stage may lead 
animals to gradual weight loss after birth as soon as weaned. This phenomenon 
has been experimentally demonstrated in dogs, kittens and mice (20;84;85). 
Granulomatous inflammation is a general description of the lesions by giant 
cell formation that can be caused by many pathogens and non-pathogens during 
chronic immune reaction due to disorders in function of macrophages (16). When 
phagocytes such as activated macrophages, are unable to "clear" ingested antigens 
due to their poor degradable nature, the cells accumulate in the tissue and develop 
in multinucleated giant cells, which will form into granulomas (89) . Activated 
macrophages in granulomas produce cytokines such as TNF-cx, IL-1 , IL-6, IFN-cx, 
which may lead to the wasting disease (28;32) . It is possible that the 
granulomatous reactions are secondary to tissue damage initiated by another 
mechanism. 
Role of PCV2 protein in immune response 
Although questions remain as to the pathogenesis of PMWS, this study 
contributed to our basic understanding of virus structure and host response. The 
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protein composition of PCV2 is unknown, but based on an analysis of the viral 
genome, PCV2 has been postulated to contain as many as 11 open reading frames 
(30) . However, western immunoblot analysis in this study demonstrated only 3 viral 
polypeptides with molecular masses of 28, 28,5, and 35kD. Of these, the 28 and 
35kD proteins matched the expected molecular weight of the polypeptides predicted 
to be encoded by ORFs 1 and 2 (30;59;60) and, on that basis, may be postulated to 
be the protein products of ORF 2 and 1, respectively. 
The 28kD protein was the most immunogenic of the 3 proteins identified, 
based on the observation that antibodies specific for this protein appeared first and 
persisted to the end of the study. Furthermore, antibody against the 28kD protein 
was not detected using PCV1 antigens on western immunoblotting. These results 
suggest that the 28kD protein may provide the antigenic basis for the development 
of diagnostic tests for the detection of PCV2-specific antibody. 
Results of western immunoblot analysis and serological monitoring data 
suggested that the 28.5kD and/or 35kD proteins were associated with the induction 
of neutralizing antibody and the 28kD protein was not. Although it is not certain 
whether the 28.5kD protein, the 35kD protein, or both are responsible for virus 
neutralization, neutralizing activity in sera appeared to correlate with the 
appearance of antibodies to the 35kD protein. Additional research is necessary to 
define the role of antibodies specific for 28.5kD and 35kD protein in viral 
neutralization. 
Although significant genetic and antigenic differences exist between PCV1 
and PCV2, some degree of cross reactivity between PCV1 and PCV2 on IFA test 
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has been demonstrated in this study as well as by other investigators (6;48). At the 
protein level , our study suggest that antibody to the 35kD protein is responsible for 
the cross-reaction. This conclusion is based on the fact that antibody from pigs 
infected with PCV2 recognized this protein in both types of PCV on western 
immunoblotting. Assuming that the 35kD protein is the protein product of ORF1, 
our conclusion is also supported by sequence analysis data demonstrating high 
DNA homology in ORF1 between PCV1 and PCV2 (30;48;59;60). Previous 
serological surveys using PCV1 demonstrated that PCV infection was common in 
swine. Data from the present study showed that earlier serological surveys would 
have detected antibodies against either PCV1 or PCV2. That being the case, PCV2 
may have been present in the swine population for quite some time and not a recent 
introduction. This conclusion is supported by a recent serological survey 
demonstrating the presence of PCV2 as early as in 1973 (111 ). 
Future study 
This study demonstrated that PCV2 is infectious for pigs. Immune ontogeny 
with role of PCV2 protein in immune response was characterized. However, the 
causal role of PCV2 in PMWS could not be conclusively demonstrated, although the 
virus appears to be a necessary component for PMWS. Therefore, the 
pathogenesis of PCV2 and PMWS remains to be further studied. If PCV2 should 
have a causal role in PMWS, all necessary co-factors should be identified for 
developing prevention and control strategies for the syndrome. 
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